– Updated Results from the Bridge Trial: Long-Term Survival and Impact of Donor Availability – Clofarabine Salvage Therapy Prior to Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapsed or Refractory AML

This article has no abstract
Epistemonikos ID: e2a204c4e585a8db3ae2018713c71c3a11908a9b
First added on: Feb 19, 2025